Skip to content
Skip to product information
Description

GLP-1 T is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) dual agonist that mimics the action of these two naturally occurring hormones in the body. This blend activates GLP receptors and research shows that this can help regulate appetite, promote satiety, and reduce caloric intake and fat—which could make it a safe and effective solution for sustainable weight management.

Our lyophilized peptides deliver 99%+ purity and are manufactured in the USA with APIs listed on the FDA Green List. We partner exclusively with cGMP and ISO 9001 registered facilities to ensure that every ingredient meets stringent purity and efficacy benchmarks, guaranteeing consistency and efficacy across all production runs. Certificate of Analysis available upon request.

Each vial is provided in lyophilized powder form and must be reconstituted with bacteriostatic water prior to use.

This product is intended for use under the guidance of qualified medical professionals who prioritize precision, quality, and evidence-based peptide therapies in patient care.

Regular price $100.00

Shipping calculated at checkout

GLP-1 T (10mg – 75mg)

Holiday Shipping Notice: We will ship as usual on Dec. 22, Dec. 27–30 and Jan. 2–3; there will be no shipping on Dec 23–26, Dec 31, and Jan 1 due to holiday hours. Normal shipping will resume on Monday, 1/2.
GLP-1 T is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) dual agonist that mimics the action of these two naturally occurring hormones in the body. This blend activates GLP receptors and research shows that this can help regulate appetite, promote satiety, and reduce caloric intake and fat

Medical NPI Required to Purchase

Description

GLP-1 T is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) dual agonist that mimics the action of these two naturally occurring hormones in the body. This blend activates GLP receptors and research shows that this can help regulate appetite, promote satiety, and reduce caloric intake and fat—which could make it a safe and effective solution for sustainable weight management.

Our lyophilized peptides deliver 99%+ purity and are manufactured in the USA with APIs listed on the FDA Green List. We partner exclusively with cGMP and ISO 9001 registered facilities to ensure that every ingredient meets stringent purity and efficacy benchmarks, guaranteeing consistency and efficacy across all production runs. Certificate of Analysis available upon request.

Each vial is provided in lyophilized powder form and must be reconstituted with bacteriostatic water prior to use.

This product is intended for use under the guidance of qualified medical professionals who prioritize precision, quality, and evidence-based peptide therapies in patient care.

GLP-1 T (10mg – 75mg)

Manufactured Only in the U.S.

Manufactured in U.S. facilities using a fully closed, traceable supply chain, ensuring consistent quality across every production run.

Highest Purity & Sterility Standards

Products are 99%+ pure, endotoxin-free, and undergo post-lyophilization sterility testing to confirm product safety and efficacy.

Certified & Documented Quality

Every product includes a Certificate of Analysis (COA), toxicology report, and MSDS, providing full visibility into safety and composition.

Regulatory-Compliant Sourcing

Manufactured from FDA Green List APIs in cGMP and ISO 9001–compliant facilities, offering providers confidence in compliant sourcing.

Mechanism of Action

How Does GLP-1 T (10mg – 75mg) Work?

GLP-1 T is a dual-agonist peptide that activates both the GLP-1 and GIP receptors designed to deliver potent synergistic effects on appetite regulation, insulin sensitivity, and metabolic control.

Through this combined incretin signaling, GLP-1 T has been shown to enhance glucose-dependent insulin release, slow gastric emptying, and significantly reduce appetite—supporting stable glycemic regulation and reduced caloric intake.

At the same time, GIP co-activation has been shown to improve metabolic flexibility, reduce adiposity, and enhance the tolerability of GLP-1–based therapy. Together, these pathways can increase insulin efficiency, promote more effective fat loss, and support comprehensive metabolic optimization, making it a powerful tool for weight-management and glucose-control strategies.

Drawer Title
Similar Products